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Purpose Snoring is the primary, most distinguishable symptom of Obstructive Sleep Apnea 
(OSA). Increased activation of the sympathetic tone is also consistently identified in adults with 
clinically diagnosed OSA. We compared heart rate variability (HRV) in snoring and non-snoring 
college-aged subjects to assess any HRV alterations between groups that could potentially 
signify an early marker for developing OSA. 
Methods 23 male snorers and 7 male non-snorer subjects were studied. The HRV variables in the 
R-R heart intervals were compared between the groups via obtaining heart rate from the polar 
RS800CX monitor and performing an analysis using an independent sample t-test. All subjects 
were of similar age, body composition, and physical fitness. 
Results HRV was not significantly reduced in snoring subjects compared to non-snoring 
subjects. Age was significantly correlated to pNN50 (r=-0.48, p=0.01), RMSSDLog (r=-0.45, 
p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00), LFnu (r=0.50, p=0.01), 
and HFnu (r=-0.50, p=0.01). 
Conclusion HRV alterations of increased sympathetic tone to parasympathetic tone are not 
significantly associated with young snorers. Increased age is correlated to elevated imbalance in 
HRV, most likely due to sympathetic build up over time as a result of increased progression of 
the sleep disorder. The HRV measure may be a useful indicator of diagnosed OSA in middle-
aged adults, but not a powerful indicator of onset OSA in younger individuals because they are at 
too early of a point in potential progression of the disorder to elicit any significant physiological 
changes. 







Obstructive sleep apnea (OSA) is characterized by repetitive cessations or decreases in 
ventilation during an individual’s sleep cycle due to intermittent bouts of partial or total collapse 
of the pharyngeal airway [1]. The after-effect of the pharyngeal airway blockages is hypoxia and 
an inadequate amount of oxygen in the blood flow delivery from the lungs to the cells of the 
body. An obstructive apneic episode results from a complete airway obstruction involving a 10 
second or greater cessation in respiration. An obstructive hypopnea is defined as a partial 
blockage in the pharyngeal airway leading to a periodic decrease in ventilation, rather than a 
complete cessation. Bouts of obstructive hypopnea can be just as severe as obstructive apnea in 
that ventilation decreases are highly associated with dramatic decreases in oxygen saturation 
[32]. Both obstructive episodes occur even with continued ventilation effort of the lungs [1]. An 
individual is diagnosed with OSA if they experience an average of five or more episodes of 
obstructive apnea or obstructive hypopnea per hour of sleep, along with encountering strong 
symptoms of excessive daytime sleepiness (EDS) [32]. EDS is a primary OSA symptom because 
it signifies sleep deprivation caused by obstructive apnea disturbances [39]. 
 
OSA is the dominant sleep disordered condition in America, affecting an estimated 15 
million adults [32].
 
Due to the high prevalence and the likelihood of the disorder to develop 
without being clinically diagnosed, OSA is a major public health concern and it is critical that 
substantial measures are taken to identify the disorder. Individuals with OSA suffer from the 
stress reaction developed from constant sleep deprival and can face long term physiological 
damage as a consequence of the oxygen deprivation during the obstructive apneas and 
hypopneas. Along with the severity of the disorder itself, OSA is also associated with a number 
7 
 
of comorbidities, which produce a greater threat to individual health. OSA has been shown to 
significantly increase the risk of cardiovascular diseases, including coronary artery disease, 
congestive heart failure, stroke, and atrial fibrillation [12]. In addition, OSA is also related to 
metabolic syndrome, hypertension, and diabetes mellitus [2-15]. 
Snoring, habitual or disruptive, is the most common sign of OSA [18-20]. Habitual and 
disruptive snoring cause poor sleep quality as well as major disturbances in sleeping patterns, 
often to the extreme extent in which breathing pauses completely [33]. Snoring occurs as a 
response to a reduction in airflow to the nose or mouth during sleep due to anatomical factors, 
which include incompetent oral muscle tone, space occupying masses, excessive length of the 
soft palate and uvula, and an obstructed nasal airway [33].
 
A relaxed oral muscle tone results in 
diminished rigid support in the mouth, which consequently leads to the falling of the tongue and 
throat muscles back into the airway creating a blockage in airflow [33]. Space occupying masses, 
specifically bulky throat tissue, cause a significant reduction in airflow because a vast amount of 
space is compromised in the pharyngeal airway
 
[33]. Due to the increased risk of snoring with 
excess bulky or fat tissue, snoring is more prevalent in overweight men than non-overweight 
men
 
[33]. Exaggerated length of the soft palate and uvula narrows the opening of airflow 
between the nose and the throat, which results in negative pressure on the pharyngeal airway 
during inspiration [33].  
Snoring, and the irregular breathing associated with OSA, has a tendency to worsen with 
age
 
[34]. Age is an important risk factor in OSA, with the highest prevalence occurring in 
middle-aged adults [35]. Other risk factors of OSA include witnessed gasping, obesity, excess 
adiposity, enlarged neck size, male gender, crowded appearing pharyngeal airway, and increased 
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blood pressure. All of these risk factors put one at higher risk for OSA and subsequently a higher 
risk of the associated cardiovascular diseases and other morbidities [11, 16-17]. 
OSA has been shown to lead to autonomic dysfunction, a key factor linking OSA to other 
chronic diseases [25]. Autonomic function can be assessed by fluctuations in normal heart rate 
rhythm. Heart rate rhythm can be evaluated by measuring heart rate variability (HRV), which is 
the variation in the time interval between heartbeats. High sympathetic drives have been 
observed in individuals that experience ventilation decreases and complete breathing cessations 
during sleep [23-24]. Previous scientific literature has demonstrated an association between 
increased prevalence in obstructive apneas and signs of high sympathetic activity [23-24]. 
During sleep, individuals with OSA undergo an over activation of the sympathetic 
nervous system, explained by the increased stimulation of peripheral and central chemoreflexes  
as the body undergoes obstructive apnea and hypopnea episodes [36]. An indirect relationship 
between oxygen and carbon dioxide occurs during bouts of obstructive apneas and hypopneas; as 
oxygen saturation decreases because of partial or complete pharyngeal airway blockage, carbon 
dioxide retention increases creating a disturbance in the balance of the gasses. An imbalance in 
gasses alerts brain receptors to stimulate the chemoreflexes to signal the sympathetic nervous 
system of the respiration acidosis [36]. Due to the cessations and decreases in ventilation, there 
are consequent decreases in venous blood return to the heart, disrupting normal blood pressure in 
the body and creating a disturbance in the heart’s normal autonomic function [37-38]. Increased 
sympathetic activity acts to maintain normal blood pressure during the obstructive sleep apneas 
via vasoconstriction of the muscles [37-38].
 
Moreover, sympathetic nervous system dominance 
between the R-R heart intervals has also been evident in hypertensive individuals
 
[25], as well as 
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individuals with coronary artery disease [21-22], demonstrating the autonomic dysfunction 
association between OSA, high blood pressure, and other cardiovascular problems [25]. 
OSA, as previously stated, is caused by airway obstruction and consequent hypoxia and 
is most commonly identified with habitual and disruptive snoring. Previous studies have been 
performed to evaluate the effects of airway obstruction and hypoxia on HRV, confirming the use 
of HRV as a key tool in measuring and identifying autonomic dysfunction in adults [26]. These 
studies consisted of measuring the HRV taken during undisturbed supine rest during a daytime 
awake period for 10 minutes [26]. Results verified the overstimulation of the sympathetic 
nervous system in OSA patients by revealing an increased ratio of low to high frequency in the 
R-R heart intervals [26].
 
Purpose  
HRV analysis had shown to be an effective screening tool in clinically diagnosed adult 
OSA patients [26], which inferred that the accuracy of the HRV measurements may have also 
been a powerful representative of indicating onset, not yet identified OSA in college aged 
snoring subjects. An objective of this study was to determine connections between heart rate 
imbalances and young snoring subjects to identify those at heightened risk for developing OSA 
by analyzing individual heart rate oscillation between beat to beat intervals and utilizing the 
knowledge that over stimulation of the sympathetic tone in HRV was seen in OSA patients. The 
goal of this study was to examine the differences in HRV between young subject snorers and 
non-snorers to determine the power of the HRV measure as an early marker of sleep disorders. 
The hypothesis of this study was that heightened sympathetic activity in HRV 
measurements would be seen in the subjects that were constant snorers, as snoring has shown to 
be the predominant risk factor of OSA, when compared to the subjects that did not snore. 
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Establishing a significant relationship between sympathetic overdrives and snoring individuals 
would help to verify HRV analysis as an appropriate tool in assessing the risk of OSA in a young 
adult population. If HRV analysis proved to be accurate in predicting the onset of OSA in 
college age persons, further measures could be taken to prevent OSA in younger individuals 
























The study aimed to obtain a sample of 40 college-aged (ages 18-26) sedentary males 
from the James Madison University and Harrisonburg community. Recruitment of subjects was 
done via flyers posted on local notice boards through campus mass emails, and also via a website 
which served as the research project’s information base by including explanations of the design 
of the study and descriptions of the testing procedures in which subjects would participate. The 
website also held actual copies of the research project study documents. The documents did not 
contain any information that allowed for subject identification.  
The aim of subject recruitment was to obtain a group of 20 snorers and a group of 20 
non-snorers to participate in the project. Subjects were required to be sedentary individuals or 
not involved in regular exercises. Physical activity levels were assessed via questionnaire to 
control for potential effects of regular exercise on autonomic function. Regular exercise may 
have an attenuated effect of the sympathetic drive on resting heart rate, which could result in an 
increase in the R-R intervals at rest [27]. This adaptation needed to be accounted for, as it may 
have corresponded with alterations in sensitivity to the autonomic system, and therefore could 
have influenced HRV data
 
[27]. 
Corresponding with a sedentary lifestyle, a body mass index (BMI) greater than 25 kg/m
2
 
was also necessary to participate in the study. A BMI value is based on the ratio of an 
individual’s body weight in kilograms to their body height squared in meters. The American 
College of Sports Medicine (ACSM) guidelines state that a BMI exceeding the value of 25 kg/m
2
 
is overweight and a BMI above 30 kg/m
2
 is considered obese [28]. Excess body weight 
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influences an individual’s risk of OSA; therefore it was crucial to have subjects of similar BMI 
values. For this study, all subjects were either overweight or obese according to ACSM 
guidelines. Other exclusionary criteria for the study included that subjects were not currently 
smoking, taking medication, or had any significant heart or lung disease.  
Pre-test: 
Subjects needed to read and sign an informed consent form. This form provided subjects 
with an overview of all aspects of the study including the study’s intentions, the risks and 
benefits of participating, the consequences (if any) of withdrawing from the study, and the 
assurance of confidentiality to the subject involved. After subjects had granted consent, they 
were told to complete questionnaires on health and sleep habits.  
The first questionnaire, the Health History Questionnaire (HHQ), asked about the 
subject’s health history to ensure that the subject had no problematic health or medical 
conditions that would have made him ineligible for the study. This questionnaire took 
approximately five minutes. Following the HHQ, subjects needed to complete four additional 
questionnaires, all which took approximately one to two minutes each. The first and second 
questionnaires included the Berlin Questionnaire (BQ) and the STOP questionnaire, both of 
which served as tools for assessing subject’s risk level for developing OSA by assessing their 
snoring habits and other potential risk factors related to OSA. The STOP questionnaire asked 
questions specifically related to snoring, tiredness during daytime, observed apnea, and high 
blood pressure
 
[40]. The third questionnaire, the Epworth Sleepiness Scale (ESS), assisted in 
evaluating the subject’s level of EDS. EDS, as stated previously before, is one of the strongest 
symptoms in identifying individuals with OSA. The last questionnaire, the International Physical 
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Activity Questionnaire (IPAQ), was used to obtain comparable estimates of the subjects’ 
physical activity levels, which was statistically accounted for in the study.  
Testing Procedure - Body Assessment: 
After completing the necessary paperwork, subjects had their weight, height, waist and 
neck circumferences, and body composition assessed. Body weight was measured to the closest 
0.1 kg via a physician’s scale, and height was assessed to the closest 0.5 cm. Waist and neck 
circumferences were also measured to the nearest 0.5 cm. Following ACSM guidelines, waist 
and neck circumferences were measured using cloth tape with a spring loaded-handle in order to 
limit the pressure of the squeeze on the bare skin [28]. 
Body composition was evaluated via Dual-energy X-ray absorptiometry (DEXA). DEXA 
scan enables the researcher to assess body composition in three compartments: fat mass, lean 
mass, and calcified tissue mass, which provides for a more detailed and accurate overview of 
body composition than most other methods. Along with examining the total percent body fat, 
DEXA scan can also be used to quantify regional visceral adiposity percentages. As stated 
previously, excessive adiposity is a risk factor for developing OSA. Visceral adiposity has a 
significantly greater correlation to individuals with OSA versus individuals without OSA. Hence, 
a subject’s visceral adiposity is important to determine via DEXA scan in order to evaluate if the 
individual does or does not have an increased risk of OSA [29]. 
Testing Procedure - Heart Rate Variability Assessment 
Prior to assessing the subject’s HRV, resting blood pressure (RBP) was measured 
according to ACSM procedures
 
[28]. Blood pressure readings were taken at heart level, while the 
subject was in a comfortable supine position with his legs uncrossed. The blood pressure cuff 
bladder was large enough to cover 80% of the subject’s upper arm circumference [28]. 
14 
 
HRV is a relatively easy, inexpensive and non-invasive way of assessing individual 
autonomic function. Variation in beat to beat intervals was correctly measured using a polar 
RS800CX monitor via a simple heart rate monitor watch system
 
[30]. Oscillation between heart 
beat intervals was detected when the subject was most relaxed in order to equally match the 
intervals occurring during a sleep cycle and produce the most accurate results. To enhance 
relaxation, a subject was guided to lay supine in a darkened room when being assessed.  
HRV, along with heart rate, was obtained by the polar RS800CX monitor over a 15 
minute time period.  The heart rate measured by the monitor during the last minute was recorded 
as the subject’s resting heart rate value because this was the minute in which the subject felt most 
relaxed during the assessment.  A normal effortless adult respiration pattern consists of 12 
breaths per minute, therefore an audible metronome was synchronized to sound at 12 beats per 
minute to try to best equalize this breathing pattern and control for any respiration effect on HRV 
variables. 
Testing Procedure: Actigraph Sleep Assessment 
After the HRV data had been recorded, each subject was given an Actigraph 
accelerometer (GT-3X plus).  The subject was told to record the time that he went to bed and the 
time that he awoken. The subject wore the Actigraph accelerometer at night while he slept to 
measure his sleep patterns and store any movement during his sleep. The device was worn 
properly on the non-dominant wrist; due to the small size and light weight of the device, it did 
not cause any pain or discomfort to the wrist. An Actigraph accelerometer had shown to be very 
reliable in measuring the sleep variability of periodic sleeping periods or waking periods during 
an entire night’s sleep cycle. Thus, the Actigraph accelerometer was used to provide practical, 
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obtainable information that no other sleep detective strategies could, such as individual recall
 
[31]. 
Statistical Analysis:  
Variables between groups were compared using an independent sample t-test, and a p-
value less than 0.05 was considered statistically significant data. Variables that were not 
normally distributed were log transformed prior to statistical analysis. Normalized LF (LFnu) 
was calculated as LFnu = LF/(TP-VLF)*100 and normalized HF (HFnu) was calculated as HFnu 
= HF/(TP-VLF)*100. Any significant differences found in terms of oscillation between R-R 
heart intervals with a dominant override of the sympathetic tone to the parasympathetic tone in 
snorers versus non snorers would be indicative of a correlation between snorers and heightened 
risk of onset OSA, considering the similar HRV patterns seen in OSA patients.  
Timeline:  
 Recruitment of subjects began in September at the start of the 2013 fall semester. The 
recruitment continued throughout the fall semester and ended at the start of the following 2014 
spring semester. If the goal of obtaining 40 sedentary male college student subjects was reached 
before that point, then the recruitment process would have ended earlier than proposed. In order 
to be pre-tested and tested, each subject reported to the Human Performance Laboratory in 
Godwin 209. The pre-test and test was administered on the same day and lasted no longer than 
one hour. The subject culminated his study participation when he returned the Actigraph 
accelerometer device to the Human Performance Laboratory the next consecutive day. The 
Actigraph accelerometer device was used for data download and analysis. The data collection 
was completed by January 2014, and the completion of the following statistical analysis of the 
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data was completed soon after. The completion research project due date was set for April 10
th
, 




























Heart Rate Variability in Habitual College-aged Snorers 
Abstract 
Purpose Snoring is the primary, most distinguishable symptom of Obstructive Sleep Apnea 
(OSA). Increased activation of the sympathetic tone is also consistently identified in adults with 
clinically diagnosed OSA. We compared heart rate variability (HRV) in snoring and non-snoring 
college-aged subjects to assess any HRV alterations between groups that could potentially 
signify an early marker for developing OSA. 
Methods 23 male snorers and 7 male non-snorer subjects were studied. The HRV variables in the 
R-R heart intervals were compared between the groups via obtaining heart rate from the polar 
RS800CX monitor and performing an analysis using an independent sample t-test. All subjects 
were of similar age, body composition, and physical fitness. 
Results HRV was not significantly reduced in snoring subjects compared to non-snoring 
subjects. Age was significantly correlated to pNN50 (r=-0.48, p=0.01), RMSSDLog (r=-0.45, 
p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00), LFnu (r=0.50, p=0.01), 
and HFnu (r=-0.50, p=0.01). 
Conclusion HRV alterations of increased sympathetic tone to parasympathetic tone are not 
significantly associated with young snorers. Increased age is correlated to elevated imbalance in 
HRV, most likely due to sympathetic build up over time as a result of increased progression of 
the sleep disorder. The HRV measure may be a useful indicator of diagnosed OSA in middle-
aged adults, but not a powerful indicator of onset OSA in younger individuals because they are at 
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too early of a point in potential progression of the disorder to elicit any significant physiological 
changes. 
Keywords: snoring, heart rate variability, sympathetic tone, obstructive sleep apnea 
Introduction 
Obstructive sleep apnea (OSA) is the dominant sleep disordered condition in America 
[32], characterized by repetitive cessations or decreases in ventilation during an individual’s 
sleep cycle due to intermittent bouts of partial (hypopnea) or total collapse (apnea) of the 
pharyngeal airway [1]. Obstructive apneic and hypopnea episodes result in hypoxia and an 
inadequate amount of oxygen in the blood, which could lead to severe physiological damage. 
Diagnosis of OSA is established with five or more episodes of obstructive apnea or hypopnea per 
hour of sleep, along with encountering strong symptoms of excessive daytime sleepiness (EDS) 
[32] as a consequence of sleep deprivation caused by the obstructive disturbances [39]. A 
definitive diagnosis of OSA most often requires a nighttime polysomnography, or an overnight 
stay at a laboratory where numerous physiological variables related to sleep staging, respiration, 
and snoring are recorded throughout the night via an electroencephalogram, electromyogram, 
and an electrooculogram [32]. The physiological variables studied include breathing flow, 
breathing effort, oxygen saturation levels, and electrical activity of the brain, muscles, and eyes 
[32]. Having OSA is detrimental to one’s health in such that a stress reaction is developed as a 
result of constant sleep restriction, and a number of comorbidities are associated with the 
disorder including cardiovascular diseases (coronary artery disease, congestive heart failure, 
stroke, atrial fibrillation) [12], metabolic syndrome, hypertension, and diabetes mellitus [2-15].  
Autonomic dysfunction, specifically an overdrive of the sympathetic nervous system 
(SNS), is a principal consequence of OSA. Heightened sympathetic drive can be explained by 
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increased stimulation of peripheral and central chemoreflexes as carbon dioxide increases and 
oxygen saturation decreases repeatedly during the night as a result of apnea and hypopnea events 
[36]. Elevated SNS has been observed at rest in individuals with OSA [23-24]. Increased 
sympathetic activity via vasoconstriction of the muscles is also a response of the body to 
maintain normal blood pressure in circumstances of decreased venous blood return to the heart 
during obstructive sleep apneas [37-38]. Fluctuations in normal heart rate rhythm can be assessed 
by evaluating the variation in the time interval between heartbeats via heart rate variability 
(HRV) analysis.  HRV analysis has been validated as a measure to evaluate autonomic function 
in adults and has verified that HRV is altered and most likely reduced in OSA patients, clinically 
meaning that there is less balance between the parasympathetic and sympathetic tone with an 
overstimulation of the SNS in OSA adults [26]. 
Snoring is a common risk factor of OSA [18-20] and occurs as a response to a reduction 
in airflow to the nose or mouth during sleep. The reduction in airflow in the pharyngeal airway is 
due to anatomical factors including relaxed oral muscle which permits the falling of tongue and 
throat muscles back into the airway [33], bulky throat tissue compromising space in the airway 
[33], and an exaggerated length of the soft palate and uvula which narrows the opening of 
airflow between the nose and the throat creating negative pressure in the airway [33]. Other 
common signs that raise the risk of OSA include older age, witnessed gasping, obesity, excess 
adiposity, enlarged neck size, male gender, crowded appearing pharyngeal airway, and increased 
blood pressure [11, 16-17]. 
Snoring is a serious risk factor for OSA, and a likely early sign of the development of 
OSA. Habitual and disruptive snoring can result in poor sleep quality as well as major 
disturbances in sleeping patterns, including the extreme breathing pauses and cessations 
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experienced in OSA patients [33]. Looking at younger snorers to see if there are any initial signs 
of altered autonomic function compared to younger non snorers will help establish if autonomic 
dysfunction is also an early risk factor for OSA.  
HRV measurements are an effective screening tool in clinically diagnosed adult OSA 
patients [26], which led to the assumption that they may be just as effective in indicating early 
signs of potential OSA in young individuals. The goal of the study was to examine the 
differences in HRV variables between college age snorers and non-snorers to determine if 
autonomic function is altered and a potential early sign of the development of OSA. Establishing 
a strong relationship between heightened sympathetic activity and snoring would help to infer 
the HRV measure as an appropriate tool in assessing the risk for young persons in developing 
OSA. 
Materials and Methods 
Subjects 
Thirty college-aged males from the James Madison University and Harrisonburg 
community participated in the study. The sample consisted of 23 snorers and 7 non-snorers.  
Subjects were not engaging in regular exercise in order to control for potential effects of 
attenuated sympathetic drive on resting heart rate that could result from exercise [27]. To 
account for similarities in excess body weight that could influence one’s risk for developing 
OSA, subjects were required to be overweight, defined by the ACSM guidelines as having a 
body mass index (BMI) greater than 25 kg/m
2
 [28]. Further inclusionary criteria for participation 
in the study included that subjects were not currently smoking, taking medication, or had any 





Subjects needed to read and sign an informed consent form regarding the study’s 
intentions, risks and benefits of participating, the consequences of withdrawing, and the 
assurance of confidentiality to the subject involved. After consent was granted, the Health 
History Questionnaire (HHQ) was to be completed followed by the Berlin Questionnaire (BQ) 
and a questionnaire related to snoring, tiredness, observed apnea, and blood pressure (STOP). 
The HHQ assessed the subject’s health and medical conditions, while the latter two evaluated the 
subject’s extent of snoring and other OSA related risk factors. The third and fourth 
questionnaires to be completed were the Epworth Sleepiness Scale (ESS) and the International 
Physical Activity Questionnaire (IPAQ). The former assessment evaluated the subject’s level of 
EDS and the latter was used to obtain comparable estimates of the subjects’ physical activity 
levels that were statistically accounted for.  
Evaluation of Body Composition 
After completing the necessary paperwork, subjects had their weight, height, waist and 
neck circumferences, resting blood pressure, and body composition (via the Dual-energy X-ray 
absorptiometry (DEXA)) assessed. All testing procedures strictly followed the ACSM guidelines 
[28].  
Evaluation of Heart Rate Variability 
Heart rate variability measures consisted of time-domain parameters as well as 
frequency-domain parameters. A time-domain HRV parameter measure corresponding to 
parasympathetic function included RMSSD, which is the square root of the mean of the squares 
of differences between continuous RR intervals [42]. Time-domain HRV parameter measures 
corresponding to both sympathetic and parasympathetic function included SDNN, which is the 
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standard deviation of all normal RR intervals, and pNN50, or the percentage of differences 
between successive RR intervals greater than 50 milliseconds [42]. A frequency-domain HRV 
parameter measure that reflected both parasympathetic and sympathetic activity was total power 
(TP), or the energy in the heart period power spectrum of all RR intervals from 0 to 0.40 Hz [42]. 
Further frequency domain HRV parameter measures included very low frequency (VLF), low 
frequency (LF), and high frequency (HF) powers, which are the energy in the heart period power 
spectrum between 0.003 and 0.04 Hz, 0.04 and 0.15 Hz, and 0.15 and 0.40Hz, respectively [42]. 
The LF/HF ratio, or the ratio of low to high frequency power, was also a frequency-domain HRV 
parameter measure. HF corresponds to parasympathetic activity and VLF, LF, and the LF/HR 
ratio correspond to sympathetic activity [42].  
Heart rate variation in beat to beat intervals was measured using a polar RS800CX 
monitor via a simple heart rate monitor watch system [30] over a 15 minute time period while 
the subject was lying supine in a dark room. Data used for analysis pertaining to oscillation 
between heart beat intervals was taken from the last five minutes of the assessment when the 
subject was most relaxed. An audible metronome was used to synchronize to sound at 12 beats 
per minute to equalize the normal adult breathing pattern and control for any respiration effect on 
HRV variables.  
Statistical Analysis 
Heart rate variables between snoring and non-snoring groups were compared using an 
independent sample t-test, and a p-value less than 0.05 was considered statistically significant 
data. Variables that were not normally distributed were log transformed prior to statistical 
analysis. Normalized LF (LFnu) was calculated as LFnu = LF/(TP-VLF)*100 and normalized 




Baseline characteristics did not differ in age, body composition variables, and physical 
fitness between subjects (Table 1). There were 6 subjects who reported they snore only 1 day per 
week, 11 subjects who reported that they snore 2 to 4 days per week, and 6 subjects who reported 
that they snore 5 days or greater per week (Table 2).  
The HRV analysis revealed no significant differences in HRV variables between snoring 
group and non-snoring group (Table 3). Although there were no significant differences between 
the non-snoring subjects and the snoring subjects, age was significantly correlated (p < 0.05) 
with particular HRV variables (Table 4). The HRV variables include pNN50 (r=-0.48, p=0.01), 
RMSSDLog (r=-0.45, p=0.01), HFLog (r=-0.49, p=0.01), Log LF/HF Ratio (r=0.53, p=0.00), 
LFnu (r=0.50, p=0.01), and HFnu (r=-0.50, p=0.01). 
Discussion 
Results from the current study show that no significant differences were found in patterns 
of HRV between snoring and non-snoring subjects. This indicates that in our group of well-
matched subjects for age, body composition variables, and physical fitness levels, snoring did not 
appear to have an impact on HRV. Moreover, no further significant differences were identified 
when running the analysis excluding the 1 day per week snorers.  
Although our findings do not reveal clear evidence of impact of snoring on HRV, snoring 
has previously shown to impact HRV in non-apneic middle-aged adults by simultaneously 
enhancing brain stem activity via inputs from mechanoreceptors [35], metabolic receptors [25, 
21], and upper airway receptors [22,31]. These receptors stimulate the peripheral and central 
chemoreflexes to elevate SNS activity when the body experiences decreases in oxygen saturation 
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[36, 46]. Reductions in oxygen saturation can be due to the partial or complete pharyngeal 
airway blockages associated with snoring [36, 46].  
Potential reasons that our results did not validate HRV alternation in snoring individuals 
compared to non-snoring individuals could be due to the tendency of snoring to worsen with age 
as well as the higher prevalence of snoring in a middle-aged population compared to a younger 
college-aged population [34]. Thus, college-aged snorers assessed in our current study may not 
have yet progressed to the level of snoring, in terms of intensity and duration, as their middle-
aged counterparts. The greater amount of apneas and hypopnea episodes accumulated over time 
from young adulthood to middle-aged adult years, the more dominant the sympathetic tone 
becomes, leading eventually to a diminished HRV [40].  Young subjects from our current study 
many not have yet built up the necessary amount of enhanced brain stem activity and 
corresponding sympathetic activity resulting from long term snoring to elicit any substantial 
changes or reductions in HRV.  
Moreover, previous literature found that HRV, with or without snoring symptoms, is 
reduced in middle-age adults [43]. This means that effects of HRV are age dependent, and as an 
individual develops from young adulthood to middle-aged years, the balances between the 
sympathetic tone and the parasympathetic tone become increasingly weakened. This theory 
offers further support to why HRV changes were not significantly evident in our younger sample 
population of our current study; simply because these chosen subjects were potentially too young 
in age to provoke any physiological deviations in heart rate that typically come in response to 
getting older.  
Furthermore, when performing a Pearson correlation matrix in our current study, results 
revealed that age was significantly associated with HRV variables pNN50, RMSSDLog, HFLog, 
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Log of LF/HF Ratio, LFnu, and HFnu. This demonstrates more distinct HRV imbalances in our 
subjects as age increased, as clear correlations were found between increasing age and 
decreasing variation in the R-R heart intervals as well as increasing age and increasing activation 
of the SNS. Hence, college-aged subjects that had the primary risk factor of snoring who were 
sampled in our procedure may have been too young and likely way too early in their progression 
of possible OSA development to display any substantial physiological adaptations from the 
disorder. Based on our results, it appears possible that with increased age, the more susceptible 
one is to see heart rate relate to snoring in terms of noticeable signs of decreased HRV and 
elevated SNS.  
Previous literature supports this analysis by finding that the non-balance in HRV found in 
individuals with OSA becomes more extreme over time [40]. One study compared the R-R heart 
interval patterns of moderate sleep apneic individuals to the R-R interval patterns of those who 
had developed further, more severe sleep apnea over time [40]. The sympathetic tone becomes 
more exaggerated and sleep apnea becomes more severe over time as a result of the continuous 
apneas and hypoxias that occur during sleep in individuals with OSA [40]. The results of this 
study showed that the LF/HF ratio was higher in the severe sleep apnea group compared to the 
moderate sleep apnea group, and a heightened LF/HF ratio corresponds to larger sympathetic 
activity [40]. This explains that with greater progression and worsening of the disorder, the 
greater was the dominance of the SNS [40]. Therefore, it is possible that even though the 
college-aged subjects assessed in our current study had a number of risk factors for OSA, this 
population may not yet be far enough advanced in the development of the potential disorder to 
display any signs of overriding sympathetic activity and corresponding HRV reduction.  
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 Furthermore, another study found similar findings in that the more severe and far along 
the sleep disorder had become, the more increased the sympathetic burst frequency and the more 
decreased the balance in the R-R heart intervals [41]. This study assessed HRV of muscle 
sympathetic nerve activity and the R-R heart intervals in 15 patients with moderate-to-severe 
OSA, 18 patients with mild OSA, and 16 healthy control subjects [41]. When comparing the 
moderate-to-severe OSA group to the mild OSA group, the former had a higher LF-to-HF ratio, 
signifying a greater dominance of the SNS compared to the PNS [41]. The moderate-to-severe 
OSA group also showed to have a lower normalized HF variability, meaning a lower overall tone 
of the PNS when compared to the mild OSA group [41]. Patients with mild sleep apnea still had 
evident abnormalities in their HRV, but these abnormalities were much less pronounced than 
those of the moderate-to-severe OSA group [41]. This study offers support to our current study 
in providing evidence that if OSA has not yet developed to a mild, moderate, or a severe level 
(which it has not in our young population sample), than HRV alterations will not be very 
prominent or may not be noticed at all, which was the case for our study.   
The limitations to our study included a small sample of control non-snorers to compare to 
the snorer group. With a larger sample, there would have been a greater chance in finding any 
statistical significant differences in the heart rate analysis data. Another limitation included that 
the amount a subject snores was self-reported by college age students. It is less likely that this 
age group has someone, for example a spouse, whom would be able to give them an accurate 
accounting of their snoring frequency.  
To summarize, our hypothesis of the study, which stated that heightened sympathetic 
activity in HRV measurements would be seen in subjects who were snorers compared to those 
that did not snore, was not supported. Hence, although HRV has shown to be a key tool in 
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measuring and identifying autonomic dysfunction in adults with already clinically diagnosed 
OSA [26], the analysis may not be as powerful of an indicator in identifying not yet diagnosed 
OSA in college aged individuals. Solely using HRV as an early marker for the disorder may be a 
disadvantage in that physiological adaptations of increased SNS activity that evolves as a 
consequence of OSA over time may have not yet developed in younger persons who snore. In 
conclusion, although the college-aged snorers sampled had several risk factors for OSA 
including snoring, being overweight to obese, and having at risk neck circumference measures, 
this population may be at too early of a point in their possible development of OSA for snoring 
to elicit any valuable physiological changes in terms of HRV reduction.  
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Age (yr) 20.3 ± 1.8 19.7 ± 2.0 
BMI (kg/m
2
) 29.1 ± 2.6 28.8 ± 3.6 
Waist (cm) 94.9 ± 10.3 89.8 ± 6.4 
Neck (cm) 40.2 ± 2.0 39.6 ± 2.4 











































Table 3- Heart Rate Variability Analysis Data 
HRV Variable Snorers  
(n=23) 
Non Snorers  
(n=7) 
SDNN (ms) 81.4 ± 38.6 81.7 ± 27.1 
pNN50 (%) 13.2 ± 9.7 18.7 ± 12.1 
RMSSDLog  1.7 ± 0.3 1.8 ± 0.3 
TPLog  3.8 ± 0.4 3.8 ± 0.4 
VLFLog  3.4 ± 0.5 3.5 ± 0.5 
LFLog  3.2 ± 0.4 3.2 ± 0.3 
HFLog  3.0 ± 0.5 3.1 ± 0.5 
Log LF/HF Ratio  2.2 ± 0.3 2.1 ± 0.5 
LFnu  60.0 ± 16.6 54.1 ± 23.7 
HFnu  40.0 ± 16.6 45.7 ± 23.7 
HRV = heart rate variability; SDNN = standard deviation of all normal R-R heart intervals; 
pNN50 = the percentage of differences between successive R-R heart intervals greater than 50 
ms; RMSSDLog = log transformed square root of the mean of the squares of differences between 
continuous R-R heart intervals; TPLog = log transformed total power; VLFLog = log 
transformed very low frequency; LFLog = log transformed low frequency, HFLog = log 
transformed high frequency; Log LF/HF Ratio = log transformed low frequency to high 











Table 4- Pearson Correlation Matrix of Age and HRV Variables among all Subjects 





SDNN (ms) -0.34 0.06 
pNN50 (%) -0.48* 0.01* 
RMSSDLog  -0.45* 0.01* 
TPLog  -0.35 0.01 
VLFLog  -0.28 0.13 
LFLog  -0.17 0.37 
HFLog  -0.49* 0.01* 
Log LF/HF Ratio  0.53* 0.00* 
LFnu  0.50* 0.01* 
HFnu  -0.50* 0.01* 
*Correlation is significant (p < 0.05) 
HRV = heart rate variability; SDNN = standard deviation of all normal R-R heart intervals; 
pNN50 = the percentage of differences between successive R-R heart intervals greater than 50 
ms; RMSSDLog = log transformed square root of the mean of the squares of differences between 
continuous R-R heart intervals; TPLog = log transformed total power; VLFLog = log 
transformed very low frequency; LFLog = log transformed low frequency, HFLog = log 
transformed high frequency; Log LF/HF Ratio = log transformed low frequency to high 















Appendix A: Email Recruitment Statement 
Sleep Research at James Madison University 
Researchers at James Madison University are recruiting young males to be subjects in a study on 
how sleep affects health.  Good candidates are: 
- 18 – 26 years old 
- NOT regular exercisers (do not exercise 3 or more times per week) 
- Not currently smoking 
- Are without significant heart or lung disease  
- Not currently taking medications  
- Have a body mass index greater than 25 [BMI = weight in kg / (height in meters)2].   
 
If you have been told that you snore, you may be a particularly good candidate.  The study would 
require subjects to complete several questionnaires about your health and sleep habits, wear a 
small device for one night while sleeping, and a complete body composition assessment.  
Subjects will receive a report on their health status including percent body fat and sleep quality.  






























Appendix B: Flyer Recruitment Statement 
James Madison University Kinesiology Department 





 18 – 26 years old men 
 NOT regular exercisers (defined as 3 or more times per week) 
 Not currently smoking 
 Are without significant heart or lung disease  
 Not currently taking medications  
 Have a body mass index greater than 25 [BMI = weight in kg / (height in meters)2]. 
 SNORERS also wanted! 
 
Study Requirements 
 Complete questionnaires on health and sleep habits 
 Wear small device on your wrist for one night while you sleep 
 Body composition measurement 
 Ultrasound imaging of blood vessels in your neck and arm 
 
Subjects Receive 
 Report on body composition (% fat) 
 Report on sleep quality 
 
To Enroll in the Study 
 Call (908) 328-4244 







Appendix C: Informed Consent 
James Madison University 
Department of Kinesiology 
Informed Consent 
Purpose 
You are being asked to volunteer for a research project conducted by Dr. Trent Hargens and 
exercise kinesiology student Erica Searfoss from James Madison University studying the 
association of snoring with autonomic dysfunction in at-risk for sleep apnea young men. 
The primary goals of this study is to examine whether the physiological alterations that are a 
result of habitual snoring in diagnosed obstructive sleep apnea (OSA) adults are evident in 
snoring at-risk not yet diagnosed younger individuals. The physiological alterations include 
reduced heart rate variability and increased sympathetic dominance.  
Experimental Procedures 
You will be asked to visit the Human Performance Laboratory (Godwin 209) 2 times, 1 – 2 days 
apart.  Your total time commitment for participation in this study will be approximately 1 hour.  
In addition, you will be asked to wear a device on your wrist for 1 night, while you sleep.  This 
will be done in your own home.  Detailed information on each visit is provided below: 
Visit 1 
Before any test is given, you will be asked to complete a prescreening and an informed consent 
form, to insure that you meet the study criteria and that you do not have any factors that would 
disqualify you from participation.  Upon completion of the informed consent, you will be asked 
to complete a short health history questionnaire providing information about your characteristics 
and health. You will then be asked complete 4 standardized questionnaires about snoring and the 
quality of your sleep, daytime sleepiness, risk for OSA, and current physical activity levels. 
You will then have your height, weight, waist circumference and neck circumference measured.  
After that, your body composition will be analyzed via a Dual-energy x-ray absorptiometer 
(DEXA).  The DEXA scan will allow us to measure your percent body fat and the mineral 
content and density of your bones.  The DEXA is much like an X-ray machine.  The DEXA will 
scan your entire body very slowly; so, you will need to lie on a table without moving for almost 
10 minutes, while the DEXA is passed over your entire body.  You will feel no discomfort 
associated with this test. 
Following the DEXA scan, we will ask that you wear a heart rate monitor while lying down in a 
darkened room for 15 minutes to get measures of your heart rate.   
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At the end of this first visit you will also be instructed on the proper use procedures for wearing 
an accelerometer to monitor your sleep for 1 night.  An accelerometer is a small device that is to 
be worn on your wrist while in bed.  You will also be asked to record the time you go to bed and 
the time you get up the following morning.   
Visit 2 
One to two days after Visit 1, you will be asked to return to Godwin 209 to return the 
accelerometer. 
Risks 
There are no risks associated with wearing an accelerometer.  Also, there is no risk associated 
with heart rate, height, weight, and waist and neck circumference measures.  A measurement 
with associated risks includes the DEXA scan.  
The amount of radiation that you will receive in the DEXA exam is less than the amount 
permitted by the Food and Drug Administration (FDA) per year. The amount you will receive is 
equal to 1/20 of a chest x-ray or no greater than you normally receive each day from your 
surroundings over the course of a week. 
Benefits 
There is no guarantee that you will get any benefit from taking part in this study.  Benefits may 
include knowledge about your health status.  You will receive information on your body 
composition, including percent body fat and bone mineral density, and an assessment of your 
sleep quality and risk for sleep apnea. 
Inquiries 
If you have any questions or concerns or you would like to receive a copy of the final aggregate 
results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu or (540) 568-5844. 
In the case of any immediate concerns or adverse reactions during the study, contact Dr. Hargens 
on his cell phone (540) 810-1310. 
Questions about Your Rights as a Research Subject 
Dr. David Cockley 
Chair, Institutional Review Board 






All data and results will be kept confidential. You will be assigned an identification code. At no 
time will your name be identified with your individual data. The researcher retains the right to 
use and publish non-identifiable data. All data will be kept secured in a locked cabinet. Final 
aggregate results will be made available to participants upon request. 
Freedom of Consent 
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind. 
I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form.  I certify that I am at least 18 





Name of Subject (Printed)      Name of Researcher (Printed) 
 
________________________________ __________________________________ 
Name of Subject (Signed)      Name of Researcher (Signed) 
 
________________________________ __________________________________ 








Appendix D: Subject Prescreening Information 








Average Exercise Habits over the Past 2 Months: 
 
Avg. # days of exercise per week: 
 
Avg. # of days of aerobic exercise per week: 
 
Avg. # of days of resistance exercise per week: 
 
Do you currently use medications of any kind? 
 
 
Have you previously been diagnosed with a heart or lung disease? 
 
 





Do you snore? 
 
If yes, do you snore:  (circle one) 
 
1 Day per week 
 
2-4 Days per week 
 































Appendix E: Health History Questionnaire 
HEALTH HISTORY QUESTIONNAIRE 
TODAY’S DATE  _______________________  
NAME  ______________________  AGE______   DATE OF BIRTH ___________________ 
ADDRESS 
__________________________________________________________________________ 
    Street   City     State    Zip  
TELEPHONE: HOME/ CELL _________/ __________    E-MAIL ADDRESS  _____ 
Person to contact in case of an emergency _________ Phone _________ (relationship) _______ 
 
Have you ever been diagnosed with cardiovascular disease?      YES     NO 
Have you ever been diagnosed with musculoskeletal disease? YES     NO 
Have you ever had any heart problems?     YES     NO 
Have you ever had Asthma?       YES     NO 
Have you ever been told by a doctor you should not exercise? YES     NO 
Are you taking any Prescription (include birth control pills) or Non-Prescription medications? 
Yes  No 
For each of your current medications, provide the following information:  









ACTIVITY LEVEL EVALUATION  
What is your occupational activity level?     Sedentary       Light       Moderate       Heavy    
Do you currently engage in vigorous physical activity on a regular basis?     Yes       No         
 If so, what type(s)? _______________________ How many days per week? __________  
   How much time per day?     <15 min       15-30 min       30-45 min       >60 min    
Do you engage in any recreational or leisure-time physical activities on a regular basis?    
  Yes       No    
   If so, what activities? 
__________________________________________________________________ 
     On average:  How often? ________ times/week;     for how long? ____________ time/session  
Do you ever have an uncomfortable shortness of breath during exercise or when doing activities?     
Yes       No 

















Appendix F: Epworth Sleepiness Scale 
Subject ID______ Name_____________________ Date Completed ____/____/____ 
 
This questionnaire asks you to indicate the chances of you becoming drowsy during hours of the 
day that you are not in bed sleeping.  “How likely are you to doze off or fall asleep in the 
following situations?” 
 
Use the following scale and indicate the most appropriate number for each situation. 
 
    0 = would never doze 
    1 = slight chance of dozing 
    2 = moderate chance of dozing 
    3 = high chance of dozing 
 
 Situation       Chance of Dozing 
 
1. Sitting and reading       _____ 
 
2. Watching T.V.       _____ 
 
3. Sitting, inactive in a public place 
 (ex.  Theatre or meeting)      _____ 
 
4. As a passenger in a car for 




5. Lying down to rest in the afternoon 
 when circumstances permit      _____ 
 
6. Sitting and talking with someone     _____ 
 
7. Sitting quietly after a lunch without alcohol    _____ 
 
8. In a car, while stopped for a few minutes 




















Appendix G: Berlin Questionnaire 
Berlin Questionnaire 
Subject ID______ Name______________________________ Date Completed ____/____/____ 
Height (cm) ___________ Weight (kg) _________ Age _____ 
Please choose the correct response to each question: 
Category 1  
1. Do You Snore? 
☐ a. Yes 
☐ b. No 
☐ c. Don’t know 
 
If you snore: 
2. Your snoring is: 
☐ a. Slightly louder than breathing 
☐ b.  As loud as talking 
☐ c.  Louder than talking 
☐ d.  Very loud – can be heard in  
 adjacent rooms 
 
3. How often do you snore? 
☐ a.  Nearly every day 
☐ b.  3-4 times a week 
☐ c.  1-2 times a week 
☐ d.  1-2 times a month 




4. Has your snoring every bothered 
other people? 
☐ a.  Yes 
☐ b.  No 
☐ c.  Don’t Know 
 
5. Has anyone noticed that you quit 
Breathing during your sleep? 
☐ a.  Nearly every day 
☐ b.  3-4 times a week 
☐ c.  1-2 times a week 
☐ d.  1-2 times a month 





6. How often do you feel tired or fatigued after you sleep? 
☐ a.  Nearly every day 
☐ b.  3-4 times a week 
☐ c.  1-2 times a week 
☐ d.  1-2 times a month 






7. During your waking time, do you feel tired, fatigued or not up to par? 
☐ a.  Nearly every day 
☐ b.  3-4 times a week 
☐ c.  1-2 times a week 
☐ d.  1-2 times a month 
☐ e.  Never or nearly never 
 
8. Have you ever nodded off or fallen asleep while driving a vehicle? 
☐ a. Yes 
☐ b. No 
 
If yes: 
9. How often does this occur? 
☐ a.  Nearly every day 
☐ b.  3-4 times a week 
☐ c.  1-2 times a week 
☐ d.  1-2 times a month 
☐ e.  Never or nearly never 
 
Category 3 
10. Do you have high blood pressure? 
☐ a.  Yes 
☐ b.  No 
☐ c.  Don’t Know
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Appendix H: STOP Questionnaire 
Stop Questionnaire 
Subject ID______ Name______________________________ Date Completed ____/____/____ 
 
Height (Inches) ___________ Weight (lbs) _________ Age _____ 
 
Neck Circumference (cm) ____________ 
 
The STOP Test consists of four questions: 
 
1. Snoring  
Do you snore loudly (louder than talking or loud enough to be heard through closed door)?  
         Yes No  
2. Tired  
Do you often feel tired, fatigued or sleepy during the day?   Yes No  
 
3. Observed  
Has anyone observed you stop breathing during your sleep?  Yes No  
 
4. Blood Pressure  
Do you have or are you being treated for high blood pressure?  Yes No  
 
 
High risk of OSA: answering yes to two or more questions  
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